SCHEMBL7130365

SCHEMBL7130365

O=C(Nc1ccc(C(=O)N2CCOCC2)cc1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.71
MEN1 O00255 5/20 0.71
CYP3A4 P08684 3/20 0.62
CYP2C9 P11712 2/20 0.62
ALDH1A1 P00352 2/20 0.62
HPGD P15428 1/20 0.62
SMN1; SMN2 Q16637 4/20 0.60
MAPT P10636 3/20 0.60
MAPK1 P28482 2/20 0.60
PPARG P37231 2/20 0.60
RORC P51449 2/20 0.60
LMNA P02545 1/20 0.60
TP53 P04637 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP2D6 P10635 1/20 0.60
PKM P14618 1/20 0.60
TSHR P16473 1/20 0.60
NFKB1 P19838 1/20 0.60
CYP2C19 P33261 1/20 0.60
THPO P40225 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7119693 0.90 MAPT (0.63) KMT2AMEN1CYP3A4CYP2C9ALDH1A1
SCHEMBL7128371 0.89 KMT2A (0.62) KMT2AMEN1CYP3A4CYP2C9ALDH1A1
SCHEMBL5502244 0.88 KMT2A (0.60) KMT2AMEN1CYP3A4CYP2C9ALDH1A1
SCHEMBL7122827 0.86 ALDH1A1 (0.72) KMT2AMEN1CYP3A4CYP2C9ALDH1A1
SCHEMBL7126991 0.86 MEN1 (0.76) KMT2AMEN1CYP3A4CYP2C9ALDH1A1
SCHEMBL7119672 0.84 ALDH1A1 (0.69) KMT2AMEN1CYP3A4CYP2C9ALDH1A1
SCHEMBL7129116 0.83 KMT2A (1.00) KMT2AMEN1CYP3A4CYP2C9SMN1; SMN2
SCHEMBL7121663 0.83 SMN1; SMN2 (0.67) KMT2AMEN1CYP3A4CYP2C9ALDH1A1
SCHEMBL22766914 0.83 SMN1; SMN2 (0.73) KMT2AALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL7120808 0.82 KMT2A (0.53) KMT2AMEN1CYP3A4CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD KMT2A 3291/4885MEN1 4865/4885CYP3A4 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.